Kamada (KMDA) Cost of Revenue (2012 - 2026)

Kamada (KMDA) posted quarterly Cost of Revenue of $26.1 million for Q1 2026, up 12.27% year-on-year from $23.3 million in Q1 2025, and down 5.73% on a QoQ basis from $27.7 million in Q4 2025.

Kamada (KMDA) Cost of Revenue (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Cost of Revenue for 15 consecutive years, with $26.1 million the latest figure, recorded in Q1 2026.

  • Quarterly Cost of Revenue rose 12.27% year-over-year to $26.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $25.9 billion (up 9.81% YoY) and the FY2025 annual result came in at $104.1 million, up 14.36% from the prior year.
  • Cost of Revenue fell to $26.1 million in Q1 2026 per KMDA's latest filing, from $27.7 million in the prior quarter.
  • Over the last five years, Cost of Revenue for KMDA reached as high as $25.8 billion in Q2 2025 and fell as low as $16.3 million in Q2 2022.
  • A 5-year average of $5.2 billion and a median of $24.5 million in 2024 frame the typical range for Cost of Revenue.
  • Annual changes were most pronounced in 2023 — Cost of Revenue surged 112287.59% — and 2024, when it sank 99.89%.
  • Year by year, Cost of Revenue stood at $30.1 million in 2022, then fell by 26.96% to $22.0 million in 2023, then slipped by 0.21% to $22.0 million in 2024, then climbed by 26.11% to $27.7 million in 2025, then fell by 5.73% to $26.1 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $26.1 million, $27.7 million, and $27.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 2.01 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 641.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn 2.59 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 133.40 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 2.36 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 13.80 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 586.00 Mn
10 Kamada 399.49 Mn 326.34 Mn 19.12 Mn 26.12 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 26.12 Mn
Mar 31, 2026 26.12 Mn
Dec 31, 2025 27.71 Mn
Dec 31, 2025 27.71 Mn
Sep 30, 2025 27.25 Mn
Sep 30, 2025 27.25 Mn
Jun 30, 2025 25.83 Bn
Jun 30, 2025 25.83 Bn
Mar 31, 2025 23.27 Mn
Mar 31, 2025 23.27 Mn
Dec 31, 2024 21.97 Mn
Dec 31, 2024 21.97 Mn
Sep 30, 2024 24.51 Mn
Sep 30, 2024 24.51 Mn
Jun 30, 2024 23.52 Bn
Jun 30, 2024 23.52 Bn
Mar 31, 2024 20.99 Mn
Mar 31, 2024 20.99 Mn
Dec 31, 2023 22.02 Mn
Dec 31, 2023 22.02 Mn